Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioImagene Meets with FDA Officials to Discuss Pre-IDE Submission of the Diagnostic Product Version of Its PATHIAM(TM) Software.


SAN MATEO San Mateo (săn mətā`ō), city (1990 pop. 85,486), San Mateo co., W Calif., on San Francisco Bay; inc. 1894. It is a commercial and retail center with some high-technology manufacturing. San Mateo, Spanish for St. , Calif. -- On Tuesday, July 5, 2005, BioImagene, Inc. met with members of the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  Food and Drug Administration's Office of In Vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment.

in vi·tro
adj.
In an artificial environment outside a living organism.
 Diagnostic Device Evaluation and Safety (FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
) to discuss the regulatory pathway for commercialization of BioImagene's PATHIAM software product. BioImagene is planning to introduce a diagnostic product version of its PATHIAM software; therefore, necessary regulatory aspects of such a product were discussed and clarified for senior executives of BioImagene in this meeting. BioImagene believes that the discussions with FDA were very useful and informative for both parties. As a result, BioImagene expects to proceed with the preparation of a pre-IDE submission to FDA for the diagnostic product version of its PATHIAM software.

"While BioImagene takes great pride in bringing innovative technology solutions for the scientific research community for betterment of patient care, it is equally committed to taking necessary steps to ensure regulatory compliance to facilitate offering of a diagnostic version of PATHIAM software product. The meeting with FDA is a major step in that direction," said Mohan Uttarwar, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of BioImagene.

About BioImagene

BioImagene provides sophisticated bio-image analysis products built on iHARNESS(TM), its proprietary technology platform. BioImagene's products allow pathologists and researchers to analyze images with far greater speed and consistency. The data management systems and web-based nature of BioImagene's technology facilitate communication and collaboration, improving the standard of pathology research and increasing the speed of drug discovery. Its scalable digital image analysis and management solutions for research use have been embraced by histopathologists, researchers, and industry alike. Through its recent acquisition of Scimagix, Inc. and its marquee product SIMS (Scientific Information Management System), BioImagene has expanded its product offerings of image informatics solutions. The company serves most of the top 15 pharmaceutical companies, including Pfizer Global R&D, Hoffmann La Roche La Roche may refer to:
  • Hoffmann-La Roche
  • La Roche College
Places
  • Belgium
  • La Roche-en-Ardenne, a small town in the Ardennes
  • Switzerland
 and Eli Lilly & Co. BioImagene is headquartered in San Mateo, California San Mateo is a city in San Mateo County, California, in the San Francisco Bay Area. It is one of the larger suburbs on the San Francisco Peninsula, located between Burlingame to the north, Foster City to the East, and Belmont to the south. . For more information on BioImagene, visit the company's web site at www.bioimagene.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 18, 2005
Words:325
Previous Article:Save the Date: 20th Annual Publicity Clinic for the California Inland Empire Chapter of the Public Relations Society of America set for Aug. 25, 2005.
Next Article:California Bartlett Pears Perfect for the ''French Women Don't Get Fat'' Lifestyle, By Georgeanne Brennan.



Related Articles
AVAILABILITY OF IMPLANTS.
BioImagene and Scimagix Merge to Provide Comprehensive Image Analysis and Informatics Solutions.
Ohio State University College of Medicine Signs a Collaboration Agreement on Digital Pathology with BioImagene.
Mediscience Technology Corp. Announces Pre-IDE Meeting Request for CD-Ratiometer, a Cancer Detection Device.
Mediscience Technology Corp. Sets Meeting Date with FDA to Review Pre-IDE Submission Regarding Cancer Detection Device; Mediscience to Meet with FDA...
Applied NeuroSolutions Takes First Step In Commercialization of Diagnostic Alzheimer's Disease Test; Company Begins Process with FDA.
Phase Forward Continues to Put Safety First; Company's Electronic Case Submissions Module 2.0, Available Immediately, Offers Streamlined Safety...
Aethlon Medical To Submit Project BioShield Related Regulatory Plan.
BioImagene Introduces Pathiam(TM) 3.0 (RUO)(1) - A Comprehensive and Affordable Digital Pathology Solution.
BioImagene Receives FDA Clearance for HER2/neu Application on Pathiam(TM) Imaging Software.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles